Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia

J. Rosenstock, M. S. Rendell, J. L. Gross, P. R. Fleck, C. A. Wilson, Q. Mekki

Research output: Contribution to journalArticlepeer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences